$OPGN question from a newbie: is official merger announce always a boost to the SP? If everybody knows merger is Monday why wouldn’t SP see that boost today? Is the official PR on the merger the catalyst and not just the knowledge ahead of time that it’s a done deal? Appreciate any help.
If you are considering getting into the day trading or penny stock market, it’s a legitimate and profitable method for making a living. Every good investor knows that in order to make money on any investment, you must first understand all aspects of it, so let’s look at daily change, stock price movement in some particular time frame, volatility update, performance indicators and technical analysis and analyst rating. Picking a stock is very difficult job. There are many factors to consider before choosing a right stock to invest in it. If picking stock was easy, everyone would be rich right? This piece of financial article provides a short snap of OpGen (OPGN) regarding Thursday trading session and presents some other indicators that can help you to support yours research about OpGen (OPGN).
OpGen (OPGN) stock Trading Summary:
OpGen (OPGN) stock changed position at 1.47% to closing price of $2.76 in recent trading session. The last closing price represents the price at which the last trade occurred. The last price is also the price on which most charts are based; the chart updates with each change of the last price. The stock registered Thursday volume of 1964026 shares. Daily volume is the number of shares that are traded during one trading day. High volume is an indication that a stock is actively traded, and low volume is an indication that a stock is less actively traded. Some stocks tend always to have high volume, as they are popular among day traders and investors alike. Other stocks tend always to have low volume, and aren’t of particular interest to short-term traders. The stock average trading capacity stands with 2.94M shares and relative volume is now at 0.67.
OpGen (OPGN) Stock Price Movement in past 50 Days period and 52-Week period
OpGen (OPGN) stock demonstrated 200.00% move opposition to 12-month low and unveiled a move of -81.84% versus to 12-month high. The recent trading activity has given its price a change of -52.08% to its 50 Day High and 102.94% move versus to its 50 Day Low. Prices of commodities, securities and stocks fluctuate frequently, recording highest and lowest figures at different points of time in the market. A figure recorded as the highest/lowest price of the security, bond or stock over the period of past 52 weeks is generally referred to as its 52-week high/ low. It is an important parameter for investors (as they compare the current trading price of the stocks and bonds to the highest/lowest prices they have reached in the past 52 weeks) in making investment decisions. It also plays an important role in determination of the predicted future prices of the stock.
OpGen (OPGN) Stock Past Performance
OpGen (OPGN) stock revealed 85.72% return for the recent month and disclosed 107.52% return in 3-month period. The stock grabbed -61.94% return over last 6-months and -75.58% return in yearly time period. To measure stock performance since start of the year, it resulted a change of 144.25%. Past performance shows you the fund’s track record, but do remember that past performance is not an indication of future performance. Read the historical performance of the stock critically and make sure to take into account both long- and short-term performance. Past performance is just one piece of the puzzle when evaluating investments. Understanding how performance fits in with your overall investing strategy – and what else should be considered – can keep you from developing tunnel vision.
Volatility in Focus:
The stock unfolded volatility at 15.13% during a week and it has been swapped around 33.02% over a month. Volatility is a rate at which the price of a security increases or decreases for a given set of returns. Volatility is measured by calculating the standard deviation of the annualized returns over a given period of time. It shows the range to which the price of a security may increase or decrease. Volatility measures the risk of a security. It is used in option pricing formula to gauge the fluctuations in the returns of the underlying assets. Volatility indicates the pricing behavior of the security and helps estimate the fluctuations that may happen in a short period of time. If the prices of a security fluctuate rapidly in a short time span, it is termed to have high volatility. If the prices of a security fluctuate slowly in a longer time span, it is termed to have low volatility.
The average true range is a volatility indicator. This stock’s Average True Range (ATR) is currently standing at 0.73. Beta factor is now at -0.42. A stock that has a beta score higher than 1 means that volatility is high, while less than 1 means that volatility is low.
Overbought and Oversold levels
The stock has RSI reading of 52.12. RSI gives an indication of the impending reversals or reaction in price of a security. RSI moves in the range of 0 and 100. So an RSI of 0 means that the stock price has fallen in all of the 14 trading days. Similarly, an RSI of 100 means that the stock price has risen in all of the 14 trading days. In technical analysis, an RSI of above 70 is considered an overbought area while an RSI of less than 30 is considered as an oversold area. RSI can be used as a leading indicator as it normally tops and bottoms ahead of the market, thereby indicating an imminent correction in the price of a security. It is pertinent to note that the levels of 70 and 30 needs to be adjusted according to the inherent volatility of the security in question.
Analyst Watch: Analysts have assigned their consensus opinion on this stock with rating of 2 on scale of 1 to 5. 1 or 2 =>Buy view 4 or 5 => Sell opinion. 3 =>Hold. Analysts’ recommendations are the fountainhead of equity research reports and should be used in tangent with proprietary research and investment methodologies in order to make investment decisions.
Given the outsized hold Artificial Intelligence (AI) technology has acquired on public imagination of late, it comes as no surprise that many are wondering what AI can do for the public health crisis wrought by the COVID-19 coronavirus.
A casual search of AI and COVID-19 already returns a plethora of news stories, many of them speculative. While AI technology is not ready to help with the magical discovery of a new vaccine, there are important ways it can assist in this fight.
Controlling epidemics is, in large part, based on laborious contact tracing and using that information to predict the spread. We live in a time in which we constantly leave digital footprints through our daily life and interactions.
These massive troves of data can be analyzed with AI technologies for detection, contact tracing and to find infection clusters, spread patterns and identify high-risk patients.
There is some evidence that AI techniques analyzing news feeds and social media data were not too far behind humans in originally detecting the COVID-19 outbreak in Wuhan.
China seems not only to have used existing digital traces but also enforced additional ones; for example, citizens in Nanjing are required to register their presence in subway trains and many shops by scanning QR codes with their cellphones.
Singapore, lauded for its effective containment of the virus without widespread lockdowns, has used public cameras to trace the interaction patterns of the infected, and even introduced a crowd-sourced app for voluntary contact tracing.
In the U.S., research efforts are underway to mine body temperature and heart-rate data from wearables for early detection of COVID-19 infection.
It is widely feared that COVID-19 cases, at their peak, will overwhelm medical infrastructure in many cities.
Evidence from Hubei, China, and Lombardy, Italy, do indeed support this fear. One way to alleviate this situation is to adopt novel methods of remotely providing medical help.
The basic infrastructure for telemedicine has existed for a long time but has been a hard-sell from consumer, provider and regulatory points of view — until now.
Already, the U.S. has waived regulations to allow doctors to practice across state boundaries; the Department of Health and Human Services (HHS) has also announced that it will not levy penalties on medical providers using certain virtual communication tools, such as Skype and FaceTime, to connect with patients.
AI technologies certainly can help as a force-multiplier here, as front-line medical decision support tools for patient-provider matching, triage and even in faster diagnosis. For example, the Chinese company Alibaba claims rapid diagnostic image analytics for chest CT scans;
China also has leveraged robots in disinfection of public spaces.
Remote tele-presence robots increasingly could be leveraged to bring virtual movement and solace to people in forced medical quarantines.
AI technologies already have been enablers of, and defenders against, fake news.
In the context of this pandemic, our incomplete knowledge coupled with angst has led to an infodemic of unreliable/fake information about coping with the outbreak, often spread by well-meaning (if gullible) people.
AI technologies certainly can be of help here, both in flagging stories of questionable lineage and pointing to more trusted information sources.
AI also can be used to distill COVID-19-related information.
A prominent example here is a White House Office of Science and Technology Policy-supported effort to use natural language-processing technologies to mine the stream of research papers relevant to the COVID-19 virus, with the aim of helping scientists quickly gain insight and spot trends within the research.
There is some hope that such distillation can help in vaccine discovery efforts, too.
Suppression by social distancing has emerged as the most promising way to stem the tide of infection.
It is clear, however, that social distancing — like sticking to a healthy diet — runs very much counter to our natural impulses.
Short of draconian state enforcement, what can we do to increase the chances that people follow the best practices? One way AI can help here is via micro-targeted “behavioral nudges.
” Like it or not, AI technologies already harvest vast troves of user profiles via our digital footprints and “weaponize” those for targeted ads.
The same technologies can be readily rejiggered for subliminal micro-targeted social distancing messages that could include distracting us from cabin fever.
There already is some evidence that mild “nudging” can even reduce the sharing of misinformation.
Lockdowns and social distancing measures are affecting the education of millions of schoolchildren.
Tutoring services assisted by AI technologies can help significantly when students are stuck at home.
China reportedly has relied on the help of online AI-based tutoring companies such as Squirrel AI to engage some of its millions of schoolchildren in lockdown.
And while self-driving cars remain a distant dream, delivering essential goods to people via deserted streets certainly could be within reach. Depending on how long shelter-at-home continues, we might rely increasingly on such technologies to transport critical personnel and goods.
Some of these potential uses of AI are controversial, as they infringe on privacy and civil liberties or reflect the very type of applications that the AI ethics community has resisted.
Do we really want our personal AI assistants to start “nudging” us subliminally? Should we support increased cellphone tracking for infection control?
It will be interesting to see to what extent society is willing to adopt them.
Indeed, our readiness to try almost anything to fight this unprecedented viral war is opening an inadvertent window into how we might handle the worries surrounding an AI-enabled future.
Ideas such as universal basic income (UBI) in the presence of widespread technological unemployment, or concerns about diminished privacy thanks to widespread AI-based surveillance — all are coming to the fore.
China has mobilized state resources to feed its quarantined population and used extensive cellphone tracking to analyze the spread of the virus. Israel is reportedly using cellphone tracking to ensure quarantines, as did Taiwan.
The U.S. is considering UBI-like ideas — e.g., providing thousand-dollar checks to many adults effectively unemployed during the pandemic — and is reportedly mulling cellphone-based tracking to get people to follow social distancing guidelines.
Once such practices are adopted, they will no longer just be theoretical constructs. Some or all of them will become part of our society beyond this war on the virus, just as many Great Depression-era programs became part of our social fabric.
The possibility that our choices in this time of crisis can change our society in crucial ways is raising alarms and calls for circumspection.
Yet, to what extent civil society is likely to pause for circumspection at the height of this “execution imperative” remains to be seen.
Subbarao Kambhampati, PhD, is a professor of computer science at Arizona State University and chief AI officer for AI Foundation, which focuses on the responsible development of AI technologies.
He served as president and is now past-president of the Association for the Advancement of Artificial Intelligence and was a founding board member of Partnership on AI. He can be followed on Twitter @rao2z.
$OPGN-FIVE TWITS, Been listening to some Comments about the BGI Test not Being "Up-To-Snuff" when compared to other available CV-19 Text. N they Bee Thinking This could Effect OPGN Stock Price. Now thinking it's bout Time for Me to Throw out a Little GOLD-DUST on the Table n See which Ones of you Sumsabritches thinks it's FOOLS-GOLD ??
1) The Merger Between these Two Companies will Combine US/Euro interest into the Same "NEWCO" Stock.
2) Curetis Parent Company Is Huge and can Throw a whole Lotta Bones to it's new Puppy-Dog to help it Grow.
3) OPGEN already Has a few FDA Approvals Pending that can Create Serious Future Revenue for the "Newco" .
4) Curetis BGI Tests were & are Still being Utilized Extensivy in many Asian & Europen Markets & this Test has a Proven Track Record.
5) The "Newco" has some Drug Resistant Pneumonia Diagnostic Texts that May Become Serious Players in the Very Near Future.
FOOLS-GOLD ??? I THINK NOT !! THIS HERE IS BONIFIED 24K BULLION !!
News 
Market Data 
Discover 
